Shares of GE HealthCare Technologies Inc. GEHC slipped 2.02% to $80.01 Friday, on what proved to be an all-around grim ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all ...

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...

At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe, i a new computed tomography (CT) system with Unlimited One-Beat Cardiac ...

The "Global Cardiac Monitors Market Analysis, 2025-2035: Focus on Product, Application, End User, and Country-Level Analysis" report has been added to ResearchAndMarkets.com's offering.The global ...

The automated system, which helps cancer detection in dense breast tissue, can advance breast cancer screening pathways.

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

The "Electrocardiogram Monitoring Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: ECG Monitor Market and ECG Electrode Market" report has been added to ...

CHICAGO, March 20, 2025--GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial ...